SGLT2 Inhibitors Reduce Gout Flares and Medication Use in Type 2 Diabetes: Study Dr Riya Dave24 April 2026 9:30 AM ISTA study published in Diabetes Care has found that SGLT2 inhibitors are associated with fewer gout flares and reduced need for gout-related...
Incretin-Based Drugs Provide Better Glycemic Control in Type 2 Diabetes, according to CGM data Dr. Shravani Dali21 April 2026 10:00 AM ISTA study published in Diabetes Care has found that incretin-based therapies, including liraglutide and sitagliptin, may offer superior glycemic control...
Pregnant Women with Controlled GDM Show No Added Obesity Risk in Offspring: Study Medha Baranwal8 April 2026 9:30 AM ISTUSA: Researchers have found in a new study that among women with gestational diabetes who maintain stable and optimal blood glucose levels during...
Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month Parthika Patel4 April 2026 2:25 PM ISTNew Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug...
Semaglutide may Improve Insulin Sensitivity in Schizophrenia Patients with Prediabetes: Study suggests Medha Baranwal14 March 2026 10:00 AM ISTDenmark: A study published in Diabetes Care has revealed that semaglutide improves insulin sensitivity in patients with schizophrenia who have...
Cipla Launches Afrezza in India: Revolutionizing Diabetes Care with Needle-Free Inhaled Insulin Dr. Bhumika Maikhuri11 March 2026 10:45 AM ISTWith many diabetes mellitus (DM) patients struggling with the challenges of multiple daily insulin injections, there is a growing need for ...
Higher testosterone levels Linked to Lower CV Risk in Men With Type 2 Diabetes: Study Dr Riya Dave21 Feb 2026 8:00 AM ISTAnalysis from the Look AHEAD trial has revealed that higher baseline testosterone levels were associated with reduced cardiovascular risk in men with...
Semaglutide Improves Glycemic Control in Adolescents With Obesity: Study Medha Baranwal13 Feb 2026 11:45 AM ISTUSA: A secondary analysis of the 68-week STEP TEENS trial, published in Diabetes Care, found that semaglutide 2.4 mg significantly improved insulin...
Maternal Diabetes may Increase Infection Risk in Early Infancy: Study Dr Riya Dave6 Feb 2026 9:30 AM ISTA study from Johns Hopkins University published in Diabetes Care has revealed that babies born to mothers with gestational or pregestational diabetes...
Adolescents with Autoimmune Diseases Face Higher Risk of Type 1 Diabetes in Adulthood: Study Shows Medha Baranwal27 Jan 2026 8:30 PM ISTIsrael: A large-scale study published in Diabetes Care has shown that adolescents with autoimmune conditions face a significantly higher risk of...
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal sheeba farhat21 Jan 2026 7:01 PM ISTMumbai: Global pharmaceutical major Lupin Limited on Tuesday announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings...
Once-Weekly Semaglutide Reduces Insulin Needs in Type 1 Diabetes, Suggests Study Medha Baranwal15 Jan 2026 10:15 AM ISTUSA: In a post hoc analysis of the ADJUST-T1D trial, adults with type 1 diabetes receiving once-weekly semaglutide 1 mg showed a significant reduction...
